Beryl Drugs Ltd share price logo

Beryl Drugs Ltd Share Price

BSE: 524606

Small Cap

Healthcare Sector

₹23.00

-0.86

(-3.60%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Beryl Drugs Ltd Stock Performance

as on September 17, 2025 at 4:01 pm IST

  • Day's Low

    Day's High

    ₹22.11
    ₹24.25
    downward going graph

    3.87%

    Downside

    5.43%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹17.35
    ₹46
    downward going graph

    24.57%

    Downside

    100.00%

    Upside

    downward going graph

Beryl Drugs Ltd share price movements today

Previous Close
₹23.86
Open
₹24.00
Volume
2,657.00
Upper Circuit
₹28.63
Lower Circuit
₹19.09
Day's Low - High
₹22.11 - ₹24.25
52 Week Low - High
₹17.35 - ₹46

Beryl Drugs Ltd Historical Returns

1 Month Return
+ 15.32 %
3 Month Return
+ 22.36 %
1 Year Return
-37.9 %
3 Year Return
+ 165.11 %
5 Year Return
+ 272.81 %

Beryl Drugs Ltd Fundamentals

as on September 17, 2025 at 4:01 pm IST

Market Cap

₹12.10 Cr

Return on Equity (ROE)

6.3

PE Ratio (TTM)

0

Return on capital employed (ROCE)

9.93

Beta (LTM)

0.59

P/B Ratio

1.13

Dividend Yield

0

PEG Ratio

0

Quarterly Earnings Growth YOY

-94.59

EPS (TTM)

0

Sector

Pharmaceuticals

Book Value

0

Technical Analysis

Bearish

View Technical Analysis

Beryl Drugs Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Beryl Drugs Ltd with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Beryl Drugs Ltd image
Beryl Drugs Ltd
NA12.1054.56%0.00-121
Shilpa Medicare Ltd image
Shilpa Medicare Ltd
BUY8,080.468.35%0.60781,286
Decipher Labs Ltd image
Decipher Labs Ltd
NA10.41-10.65%0.50-235
Syncom Formulations (India) Ltd image
Syncom Formulations (India) Ltd
NA1,699.52192.71%0.5149465
Hester Biosciences Ltd image
Hester Biosciences Ltd
NA1,754.974.93%0.7428311
See all

Beryl Drugs Ltd Stock's Interest Amongst Investors

Search interest for Beryl Drugs Ltd Stock has increased by 203% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:203% versus previous 30 day period

Beryl Drugs Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Sep 2022
Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sales
7.69
8.15
6.11
8.11
8.03
7.62
2.98
6.25
5.61
5.31
3.97
4.79
Total Income
7.9
8.19
6.09
8.17
8.09
7.66
3.21
6.29
5.65
5.4
5.22
4.84
Expenses
7.27
7.48
5.82
7.04
7.37
6.86
3.18
5.3
5.08
4.81
4.72
4.28
Operating Profit
0.42
0.67
0.29
1.07
0.66
0.76
-0.2
0.95
0.53
0.5
-0.75
0.51
Operating Profit Margin %
5.46%
8.22%
4.75%
13.19%
8.22%
9.97%
-6.71%
15.2%
9.45%
9.42%
-18.89%
10.65%
Profit Before Interest, Tax and Depreciation
0.63
0.72
0.27
1.13
0.72
0.8
0.03
0.99
0.57
0.59
0.5
0.55
Interest
0.11
0.12
0.06
0.12
0.1
0.11
0.13
0.21
0.12
0.12
0.08
0.1
Depreciation
0.19
0.22
0.15
0.28
0.29
0.31
0.32
0.28
0.33
0.31
0.32
0.38
Profit Before Tax
0.33
0.38
0.06
0.73
0.33
0.38
-0.42
0.5
0.12
0.16
0.1
0.07
Tax Paid
-0.02
0.23
-0.01
0.2
0.06
0.06
-0.07
0.13
0.1
0.1
-0.05
0.05
Profit After Tax
0.34
0.14
0.06
0.53
0.27
0.31
-0.35
0.37
0.01
0.05
0.15
0.02
Total Net profit including share of profit / Loss from associate company
0.34
0.14
0.06
0.53
0.27
0.31
-0.35
0.37
0.01
0.05
0.15
0.02
EPS
0.67
0.28
0.12
1.05
0.54
0.61
-0.68
0.73
0.01
0.1
0.3
0.04
Actual EPS
0.67
0.28
0.12
1.05
0.54
0.61
-0.68
0.73
0.01
0.1
0.3
0.04
Adjusted EPS
0.67
0.28
0.12
1.05
0.54
0.61
-0.68
0.73
0.01
0.1
0.3
0.04
Diluted EPS
0.67
0.28
0.12
1.05
0.54
0.61
-0.68
0.73
0.01
0.1
0.3
0.04

Beryl Drugs Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
11.27
15.25
12.96
12.82
14.09
14.6
26.89
26.73
21.15
Other Income
-
0.69
-
-
0.45
-
-
-
-
Total Income
11.53
15.94
13.2
13.05
14.73
14.77
27.16
27.12
22.55
Expenses
11.31
14.21
11.94
11.91
12.64
14.2
24.94
24.45
19.91
Operating Profit
-0.04
1.04
1.02
0.91
1.45
0.4
1.95
2.28
1.24
Operating Profit Margin %
-0.35%
6.82%
7.87%
7.1%
10.29%
2.74%
7.25%
8.53%
5.86%
Profit Before Interest, Tax and Depreciation
0.22
1.74
1.27
1.14
2.09
0.57
2.21
2.67
2.64
Interest
0.2
0.13
0.15
0.32
0.47
0.44
0.42
0.46
0.53
Depreciation
0.38
0.33
0.32
0.66
1.27
1.09
0.81
1.2
1.25
Profit Before Tax
-0.36
1.28
0.8
0.16
0.35
-0.96
0.98
1.01
0.86
Tax Paid
0.06
0.28
0.21
0.11
0.11
-0.29
0.22
0.24
0.29
Profit After Tax
-0.41
0.99
0.59
0.05
0.24
-0.66
0.77
0.77
0.58
Total Net profit including share of profit / Loss from associate company
-0.41
0.99
0.59
0.05
0.24
-0.66
0.77
0.77
0.58
EPS
-0.82
1.96
1.16
0.09
0.47
-1.3
1.52
1.52
1.14
Actual EPS
-0.82
1.96
1.16
0.09
0.47
-1.3
1.52
1.52
1.14
Adjusted EPS
-0.82
1.96
1.16
0.09
0.47
-1.3
1.52
1.52
1.14
Diluted EPS
-0.82
1.96
1.16
0.09
0.47
-1.3
1.52
1.52
1.14

Beryl Drugs Ltd Cash Flow

Figures in Rupees Crores

Mar 2015
Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
0.7
-0.13
0.37
-0.1
3.35
0.18
0.34
-0.47
2.48
0.82
2.64
Cash Flow from Investing Activities
0.03
0.17
0.32
0.05
1.15
-1.56
0.26
0.52
-1.3
-1.08
-0.41
Cash Flow from Financing Activities
-0.09
-0.23
-0.19
-0.36
1.61
1.67
-0.54
-0.24
-1.17
0.11
-1.55
Net Cash Flow
0.63
-0.19
0.5
-0.49
-0.04
0.3
0.06
-0.18
0.01
-0.16
0.69

Beryl Drugs Ltd Stock Shareholding Pattern

Numbers in percentages

Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Promoters
24.92%
26.38%
26.38%
26.38%
26.38%
26.38%
26.38%
26.38%
26.38%
26.38%
26.38%
Public
75.08%
73.62%
73.62%
73.62%
73.62%
73.62%
73.62%
73.62%
73.62%
73.62%
73.62%
Total Outstanding Shares
50,71,700
50,71,700
50,71,700
50,71,700
50,71,700
50,71,700
50,71,700
50,71,700
50,71,700
50,71,700
50,71,700
Total Shareholders
6,939
6,894
6,800
6,805
6,852
7,257
7,325
7,364
7,429
7,431
7,415

Beryl Drugs Ltd Earnings and Dividends

View detailed summary of the earnings and dividend history of Beryl Drugs Ltd.

  • Beryl Drugs Ltd Earnings Results

    Beryl Drugs Ltd’s net profit fell -94.59% since last year same period to ₹0.02Cr in the Q1 2025-2026. On a quarterly growth basis, Beryl Drugs Ltd has generated -86.67% fall in its net profits since last 3-months.

    Read More about Earnings Results

Insights on Beryl Drugs Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, Beryl Drugs has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, Beryl Drugs stock has moved up by 15.3%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 26.38% of holdings in Jun 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 11.9% return, outperforming this stock by 49.8%

  • imgNO EFFECT

    Retail Holding Unchanged

    img

    Retail Investor holdings remained unchanged at 73.62% of holdings in Jun 2025 quarter

About Beryl Drugs Ltd

Beryl Drugs Ltd is a leading generic pharmaceutical manufacturing company based in Indore, India, providing a range of branded and generic formulations, I.V.fluids, a range of small and large volume injectables, eye/ear drops, veterinary products and injections. Established in 1993, with operations taken over from M/s Flora and Fauna Remedies, Beryl Drugs have successfully set up a global network of pharmaceutical manufacturing research and development, contract manufacturing services, and veterinary products. The company is in compliance with WHO GMP specifications, and has also achieved ISO 9001:2000 certification for their quality management. Beryl Drugs are popular for many of their branded products like BERICEF injection, FNeuron Amplicillin INJ, PMol Biprox, BFlox and many more.

Revenue: ₹4.79Cr as on June 2025 (Q1 FY26)
Net Profit: ₹0.02Cr as on June 2025 (Q1 FY26)
Chairperson Name: Sudhir Sethi
OrganisationBeryl Drugs Ltd
IndustryPharmaceuticals
CEOSudhir Sethi
E-voting on sharesClick here to vote

FAQs

What is Beryl Drugs Ltd share price today?

Beryl Drugs Ltd share price today stands at ₹23 as on at the close of the market. Beryl Drugs Ltd share today touched a day high of ₹24.25 and a low of ₹22.11.

What is the 52 week high and 52 week low range for Beryl Drugs Ltd share?

Beryl Drugs Ltd touched a 52 week high of ₹46 and a 52 week low of ₹17.35. Beryl Drugs Ltd share price today i.e. is closed at ₹23, which is -50.00% down from its 52 week high and 32.56% up from its 52 week low.

What is Beryl Drugs Ltd's market capitalisation today?

Beryl Drugs Ltd market capitalisation is ₹12.10 Cr as on .

How to buy Beryl Drugs Ltd shares?

To buy Beryl Drugs Ltd shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for 524606 or Beryl Drugs Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Beryl Drugs Ltd shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Beryl Drugs Ltd trading volume today?

Beryl Drugs Ltd trading volume is 2,657.00 as on . This means that 2,657.00 shares of Beryl Drugs Ltd were bought and sold on the stock market during today's trading session.